Diabetes Melitus (DM). Diabetes Melitus
Conditions
Interventions
Intervention 1: Diabetan tablet will be prescribed for them 3 times per day for three months. Intervention 2: Placebo tablet will be prescribed 3 times per day for three months.
Treatment - Drugs
Placebo
Diabetan tablet will be prescribed for them 3 times per day for three months
Placebo tablet will be prescribed 3 times per day for three months.
Sponsors
Gol Daru Co.
Eligibility
Sex/Gender
All
Age
30 Years to 149 Years
Inclusion criteria
Inclusion criteria: Inclusion Criteria: 1-Having type 2 diabetes based on internal criteria with FBS=126 or more and blood glucose 200 or more in daytime. 2- HbA1C more than 7% and less than 9% 3-Not having side effects of DM 4-Non- insulin dependent 5-Willing to participate in the trial 6-Not having a crucial illness 7- psychologically normal 8- Not using any other drugs for other diseases. Excluding Criteria: 1- Hyperglycemia with HbA1C more than 250 2-2hpp more than 9% and less than 7% 3-Pragnancy and lactation 4- Using insulin 5- Not willing to enter the trial 6- Having side effects of DM 7- Cardiovascular, hepatic, renal and other major systemic diseases 8- psychologically abnormal 9- Using drugs for other illnesses 10- Type 1 DM 11- Age less than 30 years
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| HbA1C. Timepoint: At the beginning and at the end of trial (in 3 months. Method of measurement: Laboratory mg/ dl.;Lipid profile. Timepoint: At the beginning and end of the trial (in 3 months). Method of measurement: mg/dl through lab methods.;Liver and kidney parameters. Timepoint: At the beginning and end of the trial (in 3 months). Method of measurement: mg/dl through lab methods.;FBS and HbA1C. Timepoint: at the beginning of trial and every 2 weeks. Method of measurement: mg/dl. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDr Mohamad Saeed Behradmanesh
Shahrekord University of Medical Sciences
Outcome results
None listed